Retroviral Replicating Vector-mediated Gene Therapy for Ovarian Cancer

Project: Research project

Project Details

Description

Ovarian cancer is the leading cause of death in women with gynecological malignancies in the U.S., with an overall 5-year survival of
StatusActive
Effective start/end date8/1/177/31/22

Funding

  • National Institutes of Health: $511,480.00
  • National Institutes of Health: $504,040.00
  • National Institutes of Health: $504,040.00

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.